BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 15988020)

  • 1. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.
    Harmes DC; Bresnick E; Lubin EA; Watson JK; Heim KE; Curtin JC; Suskind AM; Lamb J; DiRenzo J
    Oncogene; 2003 Oct; 22(48):7607-16. PubMed ID: 14576823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
    Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
    Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm.
    Perez CA; Ott J; Mays DJ; Pietenpol JA
    Oncogene; 2007 Nov; 26(52):7363-70. PubMed ID: 17563751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1.
    Rozenfeld-Granot G; Krishnamurthy J; Kannan K; Toren A; Amariglio N; Givol D; Rechavi G
    Oncogene; 2002 Feb; 21(10):1469-76. PubMed ID: 11896574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
    Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
    Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
    Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
    Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of vitamin D receptor as a target of p63.
    Kommagani R; Caserta TM; Kadakia MP
    Oncogene; 2006 Jun; 25(26):3745-51. PubMed ID: 16462763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of p63 isoforms in female reproductive organs.
    Kurita T; Cunha GR; Robboy SJ; Mills AA; Medina RT
    Mech Dev; 2005 Sep; 122(9):1043-55. PubMed ID: 15922574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.
    Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK
    Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 and epithelial biology.
    Barbieri CE; Pietenpol JA
    Exp Cell Res; 2006 Apr; 312(6):695-706. PubMed ID: 16406339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
    Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
    Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells.
    Yugawa T; Narisawa-Saito M; Yoshimatsu Y; Haga K; Ohno S; Egawa N; Fujita M; Kiyono T
    Cancer Res; 2010 May; 70(10):4034-44. PubMed ID: 20442293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
    Hagiwara K; McMenamin MG; Miura K; Harris CC
    Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
    Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
    Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Stat3 in regulating p53 expression and function.
    Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
    Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.